Provider
QP100-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hemophilia Factor IX PA with QL
Program effective Date: Oct 14, 2020
Documents & Forms Results
Displaying 2281 - 2290 of 3159 results
Provider
QP95-20 Commercial Pharmacy Benefit Exclusion for Jelmyto®
Program effective Date: Oct 14, 2020
Provider
QP94-20 Commercial Pharmacy Benefit Exclusion for Condylox®, Lyumjev™, Veregen® and Zilxi™
Program effective Date: Oct 14, 2020
Provider
QP99-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Insulin Pump PA with QL
Program effective Date: Oct 14, 2020
Provider
QP102-20 Introducing eviCore’s new intelliPath® Technology
Program effective Date: Oct 14, 2020
Provider
QP96-20 Medical Drug Update for New to Market Inclisiran
Program effective Date: Oct 14, 2020
Provider
QP97-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hemophilia Factor VIII PA with QL
Program effective Date: Oct 14, 2020
Provider
QP98-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Fintepla® (fenfluramine) PA with QL
Program effective Date: Oct 14, 2020
Provider
QP101-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Dojolvi™ PA
Program effective Date: Oct 14, 2020
Provider
P76-20 2021 Renewal Changes Summary for Institutional Providers
Program effective Date: Oct 01, 2020